Page results
-
This page has been written by the Spasticity Team at the National Hospital for Neurology and Neurosurgery.
-
This page has been written by the Spasticity Team at the National Hospital for Neurology and Neurosurgery for patients (or their family or carers) who have been referred to our service or are under the care of the team at this hospital.
-
This page is for patients who are doing a face-to-face breath test in the hospital to test for either fructose or lactose malabsorption.
-
Fibreoptic Endoscopic Evaluation of Swallow (FEES) patient information leaflet
-
A smartphone app that identifies severe neonatal jaundice could provide a cheaper alternative to expensive screening procedures, according to a study by UCLH, UCL and the University of Ghana.
-
The National Day Care Unit provides an opportunity for many people to receive different treatments, tests and procedures without having to stay overnight in the hospital. Some eligible patients who need more than one day of treatment will stay in a hotel near to the hospital.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
This page provides information on examinations using contrast agents in MRI. It is intended for use by patients (or their families or carers) who have been referred to our service for imaging requiring contrast agents.
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
NHS England has published a proposed interim specification for the new services for children and young people experiencing gender dysphoria.
File results
-
FOI/2022/0527 - Staff data in Communications department
-
FOI/2022/0528 - Interpreting and translation services (Silent Sounds tender)
-
FOI/2022/0530 - Neonatal sepsis guidance
-
FOI/2022/0531 - Operating theatres in Trust
-
FOI/2022/0533 - Pathology service carrying out PCR testing for SARS-CoV2
-
FOI/2022/0539 - Pharmacological choices made for patients undergoing joint replacement surgery
-
FOI/2022/0557 - Patients treated with Visudyne (verteporfin)
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments